Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • CUDA Yanqi Lake Meeting | Professor Liqun Zhou: Advancing the Diagnostic Frontier to Improve Survival in Chinese Prostate Cancer Patients

    In recent years, the incidence of prostate cancer in China has continued to rise, creating an urgent need to improve diagnostic and treatment strategies tailored to this growing patient population. At the 5th Annual CUDA Yanqi Lake Meeting (2025), hosted by the Chinese Urological Doctor Association, UroStream invited Professor Liqun Zhou, Institute of Urology, Peking…

    2025.04.25
  • EAU 2025 | Professor Renée C.A. Leenen Presents 20-Year ERSPC Follow-Up, Offering New Perspectives on Prostate Cancer Screening

    UroStream: You shared the long-term follow-up data of the prostate cancer screening study at the EAU conference. Could you please share the main findings? What implications does this study bring…

    2025.04.25
  • CUDA Yanqi Lake Meeting | Professor Weijun Qin: Xenotransplantation Offers Lifesaving Hope for High-Risk Patients—A Breakthrough Led by China’s Origin

    Confronted with the challenge of key immunosuppressive drugs being unavailable in China, the team drew on over a decade of research to develop an innovative, China-specific immunotherapy protocol. The patient,…

    2025.04.25
  • CUDA Yanqi Lake | Prof. Wasilijiang Wahafu: Novel ADCs Transform First-Line Treatment of Advanced Urothelial Carcinoma

    UroStream: Chemotherapy has long been the backbone of treatment for advanced urothelial carcinoma, yet many unmet needs persist. Based on your clinical experience, could you share why cisplatin-based chemotherapy is…

    2025.04.25
  • Global First, with China’s Participation! Drs. Wenyu Yang & Wenbin An Discuss the Development, Highlights, and Clinical Relevance of the First International Expert Consensus on Pediatric Chronic Phase CML

    The recently published “Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations” in the prestigious journal Leukemia marks a historic milestone as the first international expert consensus focused on chronic-phase chronic myeloid leukemia (CML) in children and adolescents.

    2025.04.25
  • From Pioneering Efforts to Global Leadership – Academician Xiaojun Huang Charts China’s Transformative Journey

    From April 11 to 12, 2025, the Hematology Branch of the China International Exchange and Promotive Association for Medical and Health Care(CPAM) held its annual academic meeting in Qingdao, Shandong Province, alongside the “Hua Tuo Project” MDT Forum. During the event, Academician Xiaojun Huang—Conference Chair, Director of the Hematology Branch of the CPAM , and…

    2025.04.23
  • CSCO BC | “Best of SGBCC” Resonates at the National Breast Cancer Conference: Bridging Borders, Advancing Science

    On April 12, 2025, the “Best of St. Gallen 2025” session, co-hosted by the Breast Cancer Committee of the Chinese Society of Clinical Oncology (CSCO BC) and the St. Gallen International Breast Cancer Conference (SGBCC), was successfully held during the National Breast Cancer Conference in China.

    2025.04.23
  • Writing China’s Own Guidelines: Professor Zefei Jiang on the Evolution and Global Vision of the CSCO Breast Cancer Guidelines

    As one of the five initial professional guideline projects launched by the Chinese Society of Clinical Oncology (CSCO) in 2016, the CSCO Breast Cancer Guidelines (CSCO BC Guidelines) have become a cornerstone of breast cancer care in China. Since the publication of the first edition in 2017, the guidelines have undergone yearly updates, evolving in…

    2025.04.23
«previous next»
Recent Posts
  • Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
  • Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
  • Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
  • 2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
  • 2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top